These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32950103)

  • 1. miR-204-3p/Nox4 Mediates Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Tao W; Yu L; Shu S; Liu Y; Zhuang Z; Xu S; Bao X; Gu Y; Cai F; Song W; Xu Y; Zhu X
    Mol Ther; 2021 Jan; 29(1):396-408. PubMed ID: 32950103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of miR-132-3p contributes to neuronal protection in in vitro and in vivo models of Alzheimer's disease.
    Zeng C; Meng X; Mai D; Xu K; Qu S
    Behav Brain Res; 2022 Jan; 417():113584. PubMed ID: 34536429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF
    Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice.
    Ge J; Xue Z; Shu S; Yu L; Qin R; Tao W; Liu P; Dong X; Lan Z; Bao X; Ye L; Xu Y; Zhu X
    JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37192007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease.
    Xiao G; Chen Q; Zhang X
    Brain Res Bull; 2021 Dec; 177():282-294. PubMed ID: 34678444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential therapeutic and diagnostic characteristics of Alzheimer disease by targeting the miR-132-3p/FOXO3a-PPM1F axis in APP/PS1 mice.
    Fu X; Liu J; Xie J; Chen G; Zhang H; Meng F; Wu M; Li Q; Liu Y; Wang W; Dai J; Wang D; Zhao D; Li C; Wang X
    Brain Res; 2022 Sep; 1790():147983. PubMed ID: 35709892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes.
    Jiang H; Niu F; Zheng Y; Xu Y
    Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Transient Receptor Potential Melastatin 2 (TRPM2) Channel Contributes to β-Amyloid Oligomer-Related Neurotoxicity and Memory Impairment.
    Ostapchenko VG; Chen M; Guzman MS; Xie YF; Lavine N; Fan J; Beraldo FH; Martyn AC; Belrose JC; Mori Y; MacDonald JF; Prado VF; Prado MA; Jackson MF
    J Neurosci; 2015 Nov; 35(45):15157-69. PubMed ID: 26558786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice.
    Yu L; Liu Y; Jin Y; Cao X; Chen J; Jin J; Gu Y; Bao X; Ren Z; Xu Y; Zhu X
    J Alzheimers Dis; 2018; 61(4):1411-1424. PubMed ID: 29376873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
    Ji Y; Wang D; Zhang B; Lu H
    J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors.
    Xu Y; Chen P; Wang X; Yao J; Zhuang S
    Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Circulating miR-125b as a Potential Biomarker of Alzheimer's Disease in APP/PS1 Transgenic Mouse.
    Hong H; Li Y; Su B
    J Alzheimers Dis; 2017; 59(4):1449-1458. PubMed ID: 28731435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
    Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    Zhang Y; Hu Y; Han Z; Geng Y; Xia Z; Zhou Y; Wang Z; Wang Y; Kong E; Wang X; Jia J; Zhang H
    J Alzheimers Dis; 2022; 88(1):141-154. PubMed ID: 35570485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
    J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3.
    Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL
    Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
    Lu Y; Tan L; Wang X
    Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.